retatrutide latest trial results Eli Lilly infiltrates anti-obesity market as Phase III for begins Retatrutide Helped Adults With Obesity

GLP-1 medications like semaglutide reduce appetite and slow stomach emptying, which can create nutritional gaps

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

Here's what to do during a dumping syndrome episode and how to deal with it at home.

As a result, they are effective treatment options for people with T2D, achieving glycated haemoglobin reductions, weight loss and potential cardiovascular benefit, as monotherapy or as add-on to other glucose-lowering therapies

Shop Maximum NAD GLP-1 Wellness Patches (30 Count) at CanadianVit

Louisville personal injury attorney Marshall Kaufman is a partner at Kaufman & Stigger, PLLC